.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Mallinckrodt
Novartis
Cerilliant
Medtronic
Baxter
Argus Health
AstraZeneca
Federal Trade Commission
Express Scripts

Generated: July 27, 2017

DrugPatentWatch Database Preview

GUAIFENESIN Drug Profile

« Back to Dashboard

Which patents cover Guaifenesin, and what generic Guaifenesin alternatives are available?

Guaifenesin is a drug marketed by Actavis Labs Fl, Perrigo R And D, and Aurobindo Pharma Ltd. and is included in five NDAs.

The generic ingredient in GUAIFENESIN is guaifenesin; pseudoephedrine hydrochloride. There are twenty drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the guaifenesin; pseudoephedrine hydrochloride profile page.

Summary for Tradename: GUAIFENESIN

Patents:0
Applicants:3
NDAs:5
Suppliers / Packagers: see list35
Bulk Api Vendors: see list65
Clinical Trials: see list18
Patent Applications: see list2,576
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:GUAIFENESIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl
GUAIFENESIN
guaifenesin
TABLET, EXTENDED RELEASE;ORAL091009-002Sep 3, 2015OTCNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl
GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE
guaifenesin; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL091071-001May 27, 2015OTCNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
dextromethorphan hydrobromide; guaifenesin
TABLET, EXTENDED RELEASE;ORAL206941-002Mar 17, 2017OTCNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl
GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE
guaifenesin; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL091071-002May 27, 2015OTCNoNo► Subscribe► Subscribe► Subscribe
Perrigo R And D
GUAIFENESIN
guaifenesin
TABLET, EXTENDED RELEASE;ORAL078912-001Nov 23, 2011OTCNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
UBS
Federal Trade Commission
Chubb
Boehringer Ingelheim
Baxter
Covington
Johnson and Johnson
Julphar
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot